PT-141 may raise desire on its own, but context still matters
As we enter 2025, understanding the benefits and limitations of GLP-1 therapy is essential for individuals seeking effective, safe, and sustainable weight management strategies
Semaglutide carries a boxed warning about thyroid C-cell tumors in animals and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
If you are ready to take a proactive step toward feeling your best, we would love to help you get started
Clinical Evidence for Effects on Skin The topical peptide review by Schagen summarized placebo-controlled and comparative studies in which Cu-GHK products were associated with collagen production and visible skin-aging measures [2]
The results from the second semaglutide 7.2 mg phase III trial, STEP UP T2D, in adults with type 2 diabetes and obesity are expected within the next few months